European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
Bristol Myers Squibb gets European Commission nod for Opdivo in combo with cisplatin, gemcitabine for urothelial carcinoma Ruchika Sharma30 May 2024 12:49 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with...
EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma Ruchika Sharma28 April 2024 11:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations Ruchika Sharma21 Jan 2024 4:30 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
USFDA accepts for priority review Bristol Myers Squibb application for Opdivo plus Cisplatin-Based Chemotherapy for urothelial carcinoma Ruchika Sharma7 Dec 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Merck application for Keytruda plus Padcev for Urothelial Cancer gets USFDA priority review Ruchika Sharma2 Dec 2023 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Merck, Huma Therapeutics collaborate to develop digital solution for cancer patients Ruchika Sharma12 Nov 2023 11:00 AM ISTLondon: Huma Therapeutics, a global digital health company, and Merck KGaA, Darmstadt, Germany, a science and technology company, have announced...
Bristol Myers Squibb Opdivo in combo with cisplatin based chemotherapy gets EMA validation for Urothelial Carcinoma Ruchika Sharma31 Oct 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its type II variation application for...
Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma Ruchika Sharma24 Sept 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...
Natco Pharma seeks USFDA nod for generic Erdafitinib Tablets Ruchika Sharma27 July 2023 11:41 AM ISTHyderabad: NATCO Pharma Limited has announced the submission of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification...
